Invega Sustenna is a once-monthly injected medication designed to help prevent symptom relapses in schizophrenia patients who fail to take a more frequent dose of the medicine. Read Summary >
Experts are concerned that posting images and interpretations from the Rorscach test could affect the accuracy of its use with patients. Read Summary >
The House Energy and Commerce Committee has approved a sweeping bill designed to overhaul the U.S. healthcare system, clearing the way for a vote by the full House in the fall. Read Summary >
Bifeprunox did not show enough effect in a recent trial to warrant further study of the drug as a treatment for acute schizophrenia symptoms, its makers say. Read Summary >
Scientists are studying the schizophrenia prodrome--the condition's early signs--to try to find a way to stop the thought disorder when it starts. Read Summary >
Statistics show that the Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying group that represents 32 brandname drug companies, and its member companies have spent $40 million lobbying Congress as the lawmakers work to overhaul the U.S. healthcare system. Read Summary >
